| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |